Aragen announced it is establishing a new US$30M, 160,000m2 biologics manufacturing site in Bangalore, India. The facility will include multiple GMP manufacturing suites, quality control and process development labs, and downstream purification capabilities.
On 12 October 2023, the Dr Reddy’s biologics manufacturing facility in Hyderabad was issued a Form 483 from the FDA.